Drug repurposing in cancer research: a bibliometric analysis. [PDF]
Ndidi US +3 more
europepmc +1 more source
Impact of Breast Cancer on African American Women: Priority Areas for Research in the Next Decade
Lovell A. Jones, Janice A. Chilton
openalex +2 more sources
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Adherence to World Cancer Research Fund/American Institute for Cancer Research Guidelines and Mortality among Participants with Colorectal Cancer in the MEC. [PDF]
Asiimwe E +10 more
europepmc +1 more source
Stimulating cancer research in Asian communities and training the next generation of scientists
Roshan Bastani +4 more
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
A global bibliometric perspective on autophagy and tumor microenvironment in cancer research. [PDF]
Debnath I, Kundu M.
europepmc +1 more source
Stromal proteome expression profile and muscle-invasive bladder cancer research [PDF]
Haitao Niu +7 more
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source

